Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
AgFunder
San FranciscoSeed–Series C$10K – $5M
23 people
RiverVest Venture Partners
St. LouisSeed–Growth$500K – $3M
27 people
Eurazeo
ParisSeed–Late Stage
35 people
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
redalpine
ZugSeed–Growth$108K – $2.2M
28 people
Advent Life Sciences
LondonSeed–Series C
28 people
Lightstone Ventures
Portola ValleyPre-Seed–Series C
31 people
ATEL Ventures
San FranciscoSeed–Late Stage
15 people
S32
Palo AltoSeries A–Late Stage
30 people
Capricorn Venture Partners
LeuvenSeed–Growth$270K – $10.8M
30 people
Shunwei Capital
BeijingSeed–Growth
25 people
Legend Capital
BeijingSeed–Series C$2M – $10M
28 people
AME Cloud Ventures
Palo AltoSeed–Late Stage$1M – $10M
11 people
Hitachi Ventures
MunichSeed–Growth
32 people
Aisling Capital
New YorkSeed–Series C
12 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Sandbox Industries
ChicagoSeed–Growth
35 people
Dag Ventures
Palo AltoSeries B–Growth
10 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
28 people
T. Rowe Price
BaltimoreSeed–Series C
6 people
5Y Capital
ShanghaiSeed–Growth
22 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
21 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.












































































































